CClinicalTrials.gg
CompletedNCT03764397Updated Dec 5, 2018

Prehabilitation for Being Active. A Feasibility Study in Fibromyalgia

An interventional study of Prehabilitation for behavioural change in Fibromyalgia, sponsored by Universidad de Granada. Completed at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2018-12-05.

Sponsored by Universidad de Granada · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
16 Years and older
Sex
All
01

Study summary

Twelve people with FM will be recruited from the FM patient support groups. The investigators will develop and test a 4-week prehabilitation educational programme (i.e., a behavioural change intervention) consisting of meeting once per week (each approximately 1 - 1.5 hours). These dynamic and interactive meetings will focus on education and skills training in: exercise, activity cycling, pacing, causes of symptoms in FM (pain, fatigue, sleep dysfunction) and their management.

Participants will be taught to set specific, measurable, achievable, realistic and timed goals (SMART principle) that are valuable or meaningful to them. To do so, the participants will identify a 'committed action' plan. The principles of cognitive behavioural therapy will be used to address maladaptive thoughts (e.g., catastrophizing and fear avoidance) and to manage stress (e.g., skills of relaxation). Participants will learn how to use of pedometers to monitor physical activity.

After the 4-week prehabilitation educational programme, the participants will be encouraged to engage in a 6-week gentle self-paced walking programme (with weekly telephone support).

The 6-week walking programme will consist of a simple pedometer-driven intervention.

Furthermore, the research team will telephone each participant at a prearranged time each week to discuss progress, to document mean daily step count and to discuss a new physical activity target (step count) for the subsequent week. Participants will record daily step counts (pedometer-derived) in a walking dairy which will be used as raw data and mean steps per day calculated. Where a participant declines telephone support, an alternative weekly email or text/WhatsApp messages will be offered instead, where the same information will be given and requested.

Before (baseline measurements) and right after the completion of the 4-week prehabilitation educational programme as well as the 6-week gentle self-paced walking programme the same measurements will be taken. By doing so, the investigators will evaluate short and mid-term changes promoted by the prehabilitation programme. The participants will fill out the following questionnaires: the Revised FM Impact Questionnaire, Pain Catastrophizing Scale, Multidimensional Fatigue Inventory, Short-Form 36-item Health Survey, International Physical Activity Questionnaire, Sedentary Behaviour Questionnaire, Exercise Self Efficacy Questionnaire, Pittsburgh Sleep Quality Index questionnaire, and the modified 2011 preliminary FM criteria questionnaire.

Right after the completion of the prehabiliation intervention, all the participants will fill out the treatment acceptability and credibility questionnaire. Right after the completion of the walking programme, participants will be interviewed (semistructured face-to-face exit interview lasting about 30-45 minutes) to explore their experiences of the study including barriers to participation.

The main outcome of the study will be acceptability and credibility of the prehabilitation intervention (treatment acceptability and credibility questionnaire. Additionally, the success of the prehabilitation programme will be based on (i) number of sessions attended (>80%), (ii) number of drop outs (\<15%) and reasons for early withdrawal, (iii) number of screening questionnaires completed and returned (>80%).

02

Conditions studied

  • Fibromyalgia

Keywords

  • Lifestyle
  • Education
  • Self-management
  • Physical Activity
  • Proof-of-concept study
03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's enrollment of 12 is below the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Universidad de Granada is the lead sponsor of 241 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants must have been diagnosed with FM by a medical practitioner, which will be confirmed by the research team -i.e., the modified 2011 preliminary FM criteria questionnaire (Appendix 14) by satisfying 'widespread pain index' (WPI) and 'symptom severity scale' (SS) as follows, either WPI ≥7 and the SS ≥5, or the WPI is 3-6 and the SS ≥9.

Exclusion criteria

Exclusion Criteria:

  • Younger than 16 years old.
  • Not able to communicate in English.
  • Mobilise dependently/aided.
  • Have any medical condition that would make exercise participation unsafe (for example; heart disease, stroke, respiratory disease, severe mobility problems, severe arthritis or inflammatory joint disease).
  • Are involved in ongoing litigation involving FM.
  • Are currently under active treatment by a physiotherapist or involved in any other research studies.
  • Are pregnant.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Prehabilitation group

    A 4-week prehabilitation educational programme (i.e., a behavioral change intervention) and to pilot that prehabilitation in combination with a 6-week gentle self-paced walking programme (with weekly telephone support) in people with FM.

    Behavioral: Prehabilitation for behavioural change

Interventions

  • BehavioralPrehabilitation for behavioural change

    The 4-week prehabilitation educational programme will consist of a meeting for one session (approximately 1 - 1.5 hours) per week. This behavioural change programme will involve a mixture of interactive and didactic sessions, facilitated by a physiotherapist, psychologists, and other health professionals. The purpose of the initial prehabilitation programme is to gain participant 'buy-in' to the programme, to assist participants engage with exercise, to help participants overcome barriers to exercise and improve self-efficacy for exercise. The prehabilitation phase will also enable participants to understand why and how to perform gentle self-paced exercise. After the prehabilitation programme, participants will be advised to engage in a 6-week gentle self-paced walking programme; i.e., a simple pedometer-driven walking programme with weekly telephone support.

06

What researchers measure

Primary outcomes

  1. Acceptability and credibility of the prehabilitation intervention

    The treatment acceptability and credibility questionnaire

    Time frame: Time point(s): once, right after the education programme. Time frame: An average of the past 4 weeks

  2. Number of sessions attended

    Percentage of participants attending to more than 80% of the education sessions

    Time frame: Time point(s): once, right after the education programme. Time frame: The past 4 weeks

  3. Number of drop outs and reasons for early withdrawal

    Percentage of participants that do complete the study

    Time frame: Time point(s): once, right after the education programme. Time frame: The 4 past weeks

  4. Number of questionnaires completed and returned

    Percentage of participants that complete and return, at least, 80% of the questionnaires

    Time frame: Time point(s): once, right after the education programme. Time frame: The 4 past weeks

Secondary outcomes

  1. Severity of fibromyalgia (also know as, impact of fibromyalgia)

    the Revised FM Impact Questionnaire

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: The past week

  2. Pain intensity

    0-10 NRS

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: The past week

  3. Pain catastrophizing

    Pain catastrophizing is the tendency to describe a pain experience in more exaggerated terms than the average person, to ruminate on it more (e.g., "I kept thinking 'this is terrible'"), and/or to feel more helpless about the experience ("I thought it was never going to get better"). Pain catastrophizing will be measured by means of the Pain Catastrophizing Scale is a 13-item questionnaire in which patients are asked to reflect on past painful experiences and indicate their thoughts or feelings about pain, on a 5-point scale. For this study, the total score (range 0-52) was used, where higher scores represent a more negative appraisal of pain.

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: "in general", an average of the past 4 weeks.

  4. Fatigue

    the Multidimensional Fatigue Inventory

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: The past week

  5. health related quality of life

    the Short-Form Health Survey

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: "in general", an average of the past 4 weeks.

  6. physical activity

    the International Physical Activity Questionnaire

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: the past 7 days

  7. Sedentary Behaviour

    Sedentary Behaviour Questionnaire

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: the past week

  8. exercise self-efficacy

    the Exercise Self Efficacy Questionnaire

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: "in general", an average of the past 4 weeks.

  9. sleep quality

    the Pittsburgh Sleep Quality Index questionnaire

    Time frame: Time point(s): 3 (baseline, 4th and 10th weeks). Time frame: "in general", an average of the past 4 weeks.

07

Study locations

1 site
  • The VINE center
    Belfast, BT14 7DX, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided — To be decided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03764397
Lead sponsor
Universidad de Granada
Collaborators
University of Ulster
Responsible party
Fernando Estévez-López (PhD, Universidad de Granada) — Principal investigator
First posted
Dec 5, 2018
Start date
Nov 26, 2018
Primary completion
Nov 26, 2018
Completion
Nov 26, 2018
Last update
Dec 5, 2018

Study contacts

Ciara Hughes, PhD
principal investigator · Ulster University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion